Johnson & Johnson to Acquire Ambrx for $2 Billion : comparem

The acquisition strengthens Johnson & Johnson's oncology portfolio.

Related Keywords

Yusri Elsayed , Margaret Yu , Scripps Research Institute , Ambrx Biopharma Inc , Johnson , Global Therapeutic , Prostate Cancer Disease , Biologics License Application , New Drug Application , Plus Lazertinib ,